高级检索
当前位置: 首页 > 详情页

A Case-Control Study of Association Between Serum Levels of 19 Trace Elements with Prostate Cancer in Southwest China

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Public Health Laboratory Science, West China School of Public Health and West China Fourth Hospital, West China-PUMC C.C. Chen Institute of Health, Sichuan University, Chengdu 610041, China [2]Department of Urology, Institute of Urology and Center of Biomedical Big Data, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China [3]Food Safety Monitoring and Risk Assessment Key Laboratory of Sichuan Province, Chengdu, Sichuan 610041, China [4]Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), Bellinzona 6500, Switzerland
出处:
ISSN:

关键词: ICP-MS PCa Serum levels Trace element

摘要:
Prostate cancer (PCa) is the most prevalent urological malignancy, exhibiting the highest incidence and the second-highest mortality among all male cancers. The incidence of PCa in men in China is consistently rising. Studies have shown that elemental exposure levels are associated with the occurrence of PCa. However, epidemiological data are limited, and more researches on different regions and races are needed. To clarify the relationship between the occurrence of PCa and serum levels of 19 trace elements. Serum samples from 79 PCa patients and 74 male healthy controls were obtained, and the levels of 19 trace elements were measured using inductively coupled plasma mass spectrometry (ICP-MS). Baseline matching of key demographic characteristics was performed between the two groups. The relationship between serum trace elements levels and PCa, prostate-specific antigen (PSA), and PCa staging were evaluated using the Mann-Whitney U test, logistic regression, and Spearman's correlation analysis. Statistical analysis of the test results revealed that the low levels of Cu, Zn, and Se in serum may be associated with the development of PCa. Moreover, the changes in the interrelationship of trace elements may play a role in the development of PCa.© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 生物学
小类 | 3 区 生化与分子生物学 4 区 内分泌学与代谢
最新[2025]版:
大类 | 3 区 生物学
小类 | 3 区 生化与分子生物学 4 区 内分泌学与代谢
第一作者:
第一作者机构: [1]Department of Public Health Laboratory Science, West China School of Public Health and West China Fourth Hospital, West China-PUMC C.C. Chen Institute of Health, Sichuan University, Chengdu 610041, China
通讯作者:
通讯机构: [1]Department of Public Health Laboratory Science, West China School of Public Health and West China Fourth Hospital, West China-PUMC C.C. Chen Institute of Health, Sichuan University, Chengdu 610041, China [2]Department of Urology, Institute of Urology and Center of Biomedical Big Data, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China [3]Food Safety Monitoring and Risk Assessment Key Laboratory of Sichuan Province, Chengdu, Sichuan 610041, China [4]Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), Bellinzona 6500, Switzerland
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:57614 今日访问量:0 总访问量:4763 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号